Results 1 to 10 of about 10,277 (199)

Olfactory dysfunction in cystic fibrosis: Impact of CFTR modulator therapy

Journal of Cystic Fibrosis, 2022
Daniel M Beswick, Stephen M Humphries, Eszter K Vladar   +2 more
exaly  

Improving outcomes of infections in cystic fibrosis in the era of CFTR modulator therapy

Pediatric Pulmonology, 2019
Lisa Saiman
exaly  

CFTR modulator therapies in pediatric cystic fibrosis: focus on ivacaftor

Expert Opinion on Orphan Drugs, 2016
Elizabeth L Kramer, John P Clancy
exaly  

Chronic rhinosinusitis in the era of CFTR modulator therapy

Journal of Cystic Fibrosis
Roy Gavin Stone, Christopher Short, Paul McNally   +2 more
exaly  

Rapid therapeutic advances in CFTR modulator science

Pediatric Pulmonology, 2018
John P Clancy
exaly  

Wellness in the modulator era: An observational study of the impact of CFTR modulator therapy on the well-being of people with cystic fibrosis

Journal of Cystic Fibrosis
Aricca D Van Citters, Cynthia Brown, Traci M Kazmerski   +2 more
exaly  

Impact of CFTR modulator therapy on body composition as assessed by thoracic computed tomography: A follow-up study

Nutrition
Fernando Sebastian-Valles, Víctor Rodríguez-Laval, Nuria Sánchez de la Blanca Carrero   +2 more
exaly  

Hypoglycaemia after Initiation of CFTR Modulator Therapy in a Cystic Fibrosis Patient without Diabetes [PDF]

Case Reports in Endocrinology, 2023
Introduction. Cystic fibrosis transmembrane regulator (CFTR) modulator therapies improve respiratory function and glycaemic control in patients with cystic fibrosis (CF).
Marie Yskout, Joke Vliebergh, Hakan Bor, Lieven Dupont, Natalie Lorent, Pascal Van Bleyenbergh, Pieter Gillard, Bart Van der Schueren, Ann Mertens, Chantal Mathieu, Roman Vangoitsenhoven   +10 more
doaj   +2 more sources

Changes in the Cystic Fibrosis Airway Microbiome in Response to CFTR Modulator Therapy

Frontiers in Cellular and Infection Microbiology, 2021
The development of CFTR modulator therapies significantly changed the treatment scheme of people with cystic fibrosis. However, CFTR modulator therapy is still a life-long treatment, which is not able to correct the genetic defect and cure the disease ...
Buqing Yi, Alexander H Dalpke, Sébastien Boutin   +2 more
exaly   +3 more sources

Identification of early changes in multiple biomarkers following CFTR modulator initiation in patients with cystic fibrosis [PDF]

Therapeutic Advances in Respiratory Disease
Background: There are currently no early parameters that allow prediction of long-term responses to Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator treatment on an individual level.
Pascal Heer, Clara Fernandez Elviro, Angela Koutsokera, Anne Mornand, Isabelle Rochat, Nicolas Regamey, Sylvain Blanchon   +6 more
doaj   +2 more sources